|
KDM3A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.8362979459805E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.5490000000451E-06 |
| Normal-vs-Stage2 |
4.876400E-03 |
| Normal-vs-Stage3 |
9.801700E-04 |
| Normal-vs-Stage4 |
4.695600E-02 |
| Stage1-vs-Stage2 |
5.105600E-01 |
| Stage1-vs-Stage3 |
2.500400E-01 |
| Stage1-vs-Stage4 |
3.286000E-01 |
| Stage2-vs-Stage3 |
7.705600E-01 |
| Stage2-vs-Stage4 |
6.816200E-01 |
| Stage3-vs-Stage4 |
8.518000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.49949996863796E-09 |
| Normal-vs-AfricanAmerican |
6.25929999999997E-05 |
| Normal-vs-Asian |
2.620600E-01 |
| Caucasian-vs-AfricanAmerican |
9.561200E-01 |
| Caucasian-vs-Asian |
8.801400E-01 |
| AfricanAmerican-vs-Asian |
8.672400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.51249999694281E-08 |
| Normal-vs-Female |
8.4293999558227E-09 |
| Male-vs-Female |
8.741100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.596400E-03 |
| Normal-vs-Extreme_Weight |
1.183250E-03 |
| Normal-vs-Obese |
2.3414000005495E-07 |
| Normal-vs-Extreme_Obese |
3.590400E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.513000E-01 |
| Normal_Weight-vs-Obese |
2.192200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.588200E-01 |
| Extreme_Weight-vs-Obese |
9.200000E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.615000E-01 |
| Obese-vs-Extreme_Obese |
1.826640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.096300E-03 |
| Normal-vs-Age(41-60Yrs) |
3.6982972240196E-11 |
| Normal-vs-Age(61-80Yrs) |
3.92540000000441E-05 |
| Normal-vs-Age(81-100Yrs) |
2.139200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.138000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.103500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.701700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.235500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.399620E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.652800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.30849808555445E-11 |
| Normal-VS-Type2 PRCC |
1.337750E-02 |
| Normal-VS-KIRP CIMP |
4.057900E-03 |
| Normal-VS-Unclassified PRCC |
1.598180E-03 |
| Type1 PRCC-VS-Type2 PRCC |
7.615100E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.498000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.369000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.195670E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.280200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.593800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.270300E-02 |
| Normal-vs-N1 |
7.199400E-04 |
| Normal-vs-N2 |
1.971960E-01 |
| N0-vs-N1 |
8.876300E-03 |
| N0-vs-N2 |
5.642200E-02 |
| N1-vs-N2 |
9.618000E-01 |
|
|
